SMi Group Announce the Top 10 Reasons to Attend RNA Therapeutics 2015

LONDON - Jan. 21, 2015 - PRLog -- SMi’s RNA Therapeutics returns for the 6^th year on the 16^th – 17^th February in Central London and will provide progressive insights into recent developments and growth drivers in the RNA Therapeutics arena. The event will feature a packed agenda of over 20 case study driven presentations, speakers representing both industry and academia, 2 interactive workshops, a panel debate, a round table discussion, plus over 3 hours of networking.

Top 10 reasons to attend:

• EXPERTISE: Expanding scientific horizons for over 5 years, RNA Therapeutics will once again play host to a global audience of chief scientists, academia and industry specialists, providing a focal point to discuss market access, modifications and formulations.

• HEAR FROM THE EXPERT SPEAKER LINE-UP: The packed agenda will feature 20 presentations including keynotes from Silence Therapeutics, GSK, AstraZeneca, Sarepta Therapeutics and the University of Oxford.

• HEAR CASE STUDIES: Hear an array of case study led addresses from market experts such as Roche, CRISPR Therapeutics, MiNA Therapeutics plus many more.

• ENGAGE IN OVER 10 HOURS OF CONTENT: Immerse yourself in a universe of new insights on key topics such as gene editing technologies, hepatic targeting, viral delivery, exon skipping in Duchenne Muscular Dystrophy and RNA splicing.

• JOIN THE ROUND TABLE DISCUSSION: Discuss developing RNA therapeutics for rare diseases in a round table led by the Chief Medical Officer and SVP of R&D, Giles Campion. With over 20 years’ experience in the pharmaceutical and biotechnology industries, Dr Campion will identify current challenges and discuss market place opportunities.

• JOIN THE DEBATE: A panel debate on collaborative working from academia to big pharma will be led by Silence Therapeutics Chief Scientific Officer, Joerg Kaufman. With over 18 years’ experience in both the United States and Europe, Dr Kaufman will be exploring the role of collaborative models and platform providers.

• BENEFIT FROM THE INTERACTIVE WORKSHOP: The interactive post conference workshop entitled: RNAi therapeutics; appreciating the gap in delivery from preclinical studies to clinical success, will be hosted by GlobalAcorn Ltd and the University of Leeds. A must attend for all those puzzled about what it is really going to take to move from successful RNAi therapy experiments in preclinical models of human disease to effective implementation of RNAi type therapeutics in clinic.

• EXPAND KNOWLEDGE ON PATENT BIOTECH INNOVATIONS: James Legg, Patent Attorney from Boult Wade Tennant will answer questions like: Why use a patent to protect biotech innovation? What are the implications of when to file and what do you include in your patent application? and more…

• NETWORKING: Ample opportunity for discussion, including 2 morning coffee breaks, 2 networking lunches and 2 afternoon tea sessions. Make new contacts, meet old friends and form the relationships you can count on in the future.

• EARLY BIRD: Register now and benefit from the £100 early bird discount at http://www.smi-online.co.uk/goto/2015rna53.asp

Sponsored by Lipocalyx and Silence Therapeutics Plc

Contact Magdalena Georgieva on +44 (0)20 7827 6148 or email: mgeorgieva@smi-online.co.uk

------------------------- END --------------------------

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk